Table 1 Assessments by time point

Screening fully

    Medical diagnosis, current smoking, and other inclusion/exclusion criteria

X

    Cognitive functioning (MMSE [43])

X

Participant characteristics

    Demographics (age, race, etc.)

X

    Medical and smoking history

X

    Nicotine dependence (FTND [50])

X

    Motivation to quit (contemplation ladder [51])

X

X

    MN withdrawal scale [52]

X

Primary outcomes

    Current smoking/smoking since last contact

X

X

X

X

X

X

    Use of other tobacco products

X

X

X

X

X

X

    Saliva sample for cotinine testing

X

X

X

    Exhaled breath sample for CO testing

X

X

X

    Depressive symptoms (PHQ-9 [53])

X

X

X

X

X

    Depressive symptoms (CESD-10 [66])

X

X

X

X

Secondary outcomes

    Positive and negative affect (PANAS [57])

X

X

X

X

X

    Reactive anhedonia (SHAPS [68, 69])

X

X

X

X

    Perceived stress scale (PSS-4 [70])

X

X

X

    Health related quality of life (SF-12 [71])

X

X

X

    Exercise tolerance (DASI [72])

X

X

X

    MACE/mortality

X

X

X

    Adverse event monitoring

X

X

X

X

X

Hypothesized BA mediators

    Pleasant/valued activities (BADS [76], PES [79, 80])

X

X

X

Acceptability

    Treatment acceptability (CSQ-8 [81])

X

Potential confounders

    Medication adherence questions [88, 89]

X

X

X

    Diet/exercise questions [92]

X

X

X

    Counseling sessions attended

X

    Cardiac rehabilitation attendance

X

X

    Outside of study depression treatment

X

X

    Outside of study smoking cessation treatment

X

X